PDA/FDA Joint Regulatory Conference
• Presenting (9/14): “ICH Q9(R1) in the Real World: From Subjective Judgement to Knowledge and Science-Based, Transparent, and Inspectable Risk-Based Decisions” – Amanda McFarland
• Moderating (9/15): “C4: Navigating Complexities of Raw Materials in the Manufacturing of Advanced Modalities” – Marc Glogovsky
• Interest Group Leader (9/16): “IG3: Quality Risk Management” – Amanda McFarland
• Attending (9/14-9/16): Kelly Waldron, Steve Langille, Erika Pfeiler, Igor Gorsky, and Ryan Murray